Immuneering Corporation (IMRX) Tops Q3 EPS by 3c

Immuneering Corporation (NASDAQ: IMRX) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)